Back

OCEANIC-AF - Asundexian versus apixaban in patients with atrial fibrillation

1 September 2024 (08:40 - 09:00)
Organised by: Logo
Congress Presentation Part of: HOT LINE 6 Oral Anticoagulation ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Manesh Patel

Duke University, Durham (United States of America)

8 More presentations in this session

Presentation thumbnail
STEEER-AF - Stroke prevention and rhythm control therapy
Professor D. Kotecha (Birmingham, GB)
Slides Video
Presentation thumbnail
Discussant review - STEEER-AF
Professor C. Granger (Durham, US)
Slides Video
Presentation thumbnail
Panel discussion - STEEER-AF
Video
Presentation thumbnail
Discussant review - OCEANIC-AF
Professor E. Hylek (Boston, US)
Slides Video
Presentation thumbnail
Panel discussion - OCEANIC-AF
Video

Access the full session

Session thumbnail
HOT LINE 6
Video

The Event

Event poster

ESC Congress 2024

1 September 2024 08:40 CET
You may be interested in
thumbnail
Congress Presentation
Safety of the oral Factor XIa inhibitor asundexian compared with apixaban in patients with atrial fibrillation (PACIFIC-AF).
29 August 2022
thumbnail
Congress Presentation
OCEAN; AF Recurrence
12 April 2026
thumbnail
Congress Presentation
NOAH-AFNET 6: Oral anticoagulation in patients with atrial high rate episodes
25 August 2023
thumbnail
Congress Presentation
PACIFIC-STROKE - Phase 2 Program of AntiCoagulation via Inhibition of FXIa by the oral Compound BAY 2433334 – non-cardioembolic STROKE study.
28 August 2022

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources